Search | ARVO Journals

Showing 1 – 20 of 1482

SORT: Best Match Most Recent Oldest

VIEW: Basic | Expanded

ARVO Annual Meeting Abstract June 2020

Atypical Presentations of Birdshot Chorioretiopathy: A Comparative Longitudinal Study

Samera Ahmad; Kenneth Warren Price; Steven Yeh; Ghazala O'Keefe; Jessica Gowramma Shantha

Invest. Ophthalmol. Vis. Sci.. 2020; 61(7):2087. doi:

Articles July 2021

Peripapillary Choroidal Vascularity Outside the Macula in Patients With Central Serous Chorioretinopathy

PDF

Young Ho Kim; Boram Lee; Edward Kang; Jaeryung Oh
TAGS: central serous chorioretinopathy, cortical blindness, macula lutea
Trans. Vis. Sci. Tech.. 2021; 10(8):9. doi: https://doi.org/10.1167/tvst.10.8.9

Includes: Supplemental Content

ARVO Annual Meeting Abstract June 2021

Genome-wide transcriptional responses of human choroidal endothelial cells to corticosteroids as a model for central serous chorioretinopathy

Joost Brinks; Elon van Dijk; Szymon Kielbasa; Hailang Mei; Paul Quax; Onno Meijer; Camiel J F Boon

Invest. Ophthalmol. Vis. Sci.. 2021; 62(8):43. doi:

ARVO Annual Meeting Abstract June 2021

Psychological Stress during COVID-19 and Central Serous Chorioretinopathy (CSCR)

Mathilde Franklin; Alan Wagner; Kapil Kapoor

Invest. Ophthalmol. Vis. Sci.. 2021; 62(8):1971. doi:

ARVO Annual Meeting Abstract June 2021

Subretinal choroidal neovascularization in central serous chorioretinopathy resistant to mineralocorticoid receptor antagonists

Alexis Kassotis; Vlad Diaconita; Tongalp H Tezel

Invest. Ophthalmol. Vis. Sci.. 2021; 62(8):637. doi:

ARVO Annual Meeting Abstract June 2021

One year outcome and predictors of treatment outcome in central serous chorioretinopathy (CSCR): multimodal imaging based analysis

Supriya Arora; Dmitrii S Maltsev; Sumit Singh; Niroj Kumar Sahoo; Deepika Parameshwarappa; Tarun Arora; Alexei Kulikov; Claudio Iovino; Filippo Tatti; Ramkailash Gujar; Ramesh S Venkatesh; Nikitha Reddy; Ram Snehith; Enrico Peiretti; Marco Lupidi; Jay Chhablani

Invest. Ophthalmol. Vis. Sci.. 2021; 62(8):3295. doi:

ARVO Annual Meeting Abstract June 2021

Choroidal vascularity map in unilateral central serous chorioretinopathy : A comparison with fellow eyes

Niroj Kumar Sahoo; Sumit Singh; Oliver Beale; Gideon Nkrumah; Mohammed Abdul Rasheed; Kiran Kumar Vupparaboina; Filippo Tatti; Khushboo Chandra; Claudio Iovino; Enrico Peiretti; Jay Chhablani

Invest. Ophthalmol. Vis. Sci.. 2021; 62(8):2183. doi:

ARVO Annual Meeting Abstract June 2021

Choroidal Vascularity in Chronic Central Serous Chorioretinopathy

Rebecca Kaye; Tunde Peto; Andrew J Lotery

Invest. Ophthalmol. Vis. Sci.. 2021; 62(8):1902. doi:

ARVO Annual Meeting Abstract June 2021

Effect of Photodynamic Therapy on Choroidal Indices in Patients with Central Serous Chorioretinopathy

Muhammad Hassan; Sarakshi Mahajan; Maria Soledad Ormaechea; Rupesh V Agrawal; Quan Dong Nguyen; Ruwan Amila Silva

Invest. Ophthalmol. Vis. Sci.. 2021; 62(8):2845. doi:

ARVO Annual Meeting Abstract June 2021

Peripapillary Halos in Inflammatory Optic Neuritis of Birdshot Chorioretinopathy

Raquel Goldhardt; Mohamed Khodeiry; Xiangxiang Liu; Thomas Arno Albini; Mohamed S Sayed; Giovanni Gregori; Richard K Lee

Invest. Ophthalmol. Vis. Sci.. 2021; 62(8):2411. doi:

ARVO Annual Meeting Abstract June 2021

The significance of double layer sign in eyes with choroidal neovascularization secondary to central serous chorioretinopathy

Ahmed M Hagag; Rajna Rasheed; Sobha Sivaprasad

Invest. Ophthalmol. Vis. Sci.. 2021; 62(8):1922. doi:

ARVO Annual Meeting Abstract June 2021

Macular Neovascularization Associated with Central Serous Chorioretinopathy: Multimodal Imaging-Based Predictors

Thamolwan Surakiatchanukul; Supriya Arora; Dmitri Maltsev; Sumit Singh; Niroj Kumar Sahoo; Deepika Parameshwarappa; Alexei Kulikov; Claudio Iovino; Filippo Tatti; Ramkailash Gujar; Ramesh S Venkatesh; Nikitha Reddy; Ram Snehith; Enrico Peiretti; Marco Lupidi; Jay Chhablani

Invest. Ophthalmol. Vis. Sci.. 2021; 62(8):650. doi:

ARVO Annual Meeting Abstract June 2021

Difference in characteristics of central serous chorioretinopathy with and without choroidal neovascularization on OCT angiography

Yuki Komuku; Xiaoyin Zhou; Takashi Araki; Hiroto Terasaki; Akiko Miki; Soichiro Kuwayama; Tomo Nishi; Takamasa Kinoshita; Fumi Gomi

Invest. Ophthalmol. Vis. Sci.. 2021; 62(8):634. doi:

ARVO Annual Meeting Abstract June 2021

Automated Detection of Inflammatory Activity in Sarcoid Uveitis and Birdshot Chorioretinopathy Patients Using Optical Coherence Tomography and Fluorescein Angiography

Cindy Chen; Sumit Sharma; Arthi Venkat; Kimberly Baynes; Emily Fisher; Danielle Burton; Jordan Deaner; Michael Ramos; Naveen Karthik; Kayvan Barekatain; Phuoc-Hanh Le; Jasmin Bhangu; Megan Ann McDonald; Peter M Kaiser; Justis P Ehlers; Sunil K. Srivastava

Invest. Ophthalmol. Vis. Sci.. 2021; 62(8):1435. doi:

ARVO Annual Meeting Abstract June 2021

Dexamethasone intravitreal implant as monotherapy for birdshot chorioretinopathy

Minh Trinh; Jonathan Jonisch

Invest. Ophthalmol. Vis. Sci.. 2021; 62(8):1400. doi:

ARVO Annual Meeting Abstract June 2021

Clinical Outcome of Anti-VEGF in type 1 Choroidal Neovascularization secondary to Central Serous Chorioretinopathy

Jong Beom Park; Kiyoung Kim; Eung Suk Kim; Seung-Young Yu

Invest. Ophthalmol. Vis. Sci.. 2021; 62(8):1914. doi:

ARVO Annual Meeting Abstract June 2021

Long-term changes of fundus autofluorescence in chronic central serous chorioretinopathy

Junwoo Lee; Kiyoung Kim; Eung Suk Kim; Seung-Young Yu

Invest. Ophthalmol. Vis. Sci.. 2021; 62(8):1913. doi:

ARVO Annual Meeting Abstract June 2021

The value of OCT angiography (OCTA) to discriminate neovascular central serous chorioretinopathy（nCSC）

Zhaoxia Zhang; Bin Sun; Chunfang Yan

Invest. Ophthalmol. Vis. Sci.. 2021; 62(8):2498. doi:

ARVO Annual Meeting Abstract June 2021

Endpoint management in central serous chorioretinopathy

Noor-Ul-Ain Shekoh; Quratulain Shekoh; Victor Gonzalez

Invest. Ophthalmol. Vis. Sci.. 2021; 62(8):2206. doi:

ARVO Annual Meeting Abstract June 2021

Galectin 3 and Central Serous Chorioretinopathy: a promising new biomarker

Marta Zola; Camille Gobeaux; Thara Javorsky; Magda Meester-Smoor; Suzanne Yzer; Francine F Behar-Cohen

Invest. Ophthalmol. Vis. Sci.. 2021; 62(8):2197. doi:

1 2 3 4 5

Next 20 Results »

Search Results for Chorioretinopathy

NARROW

Content Type

Journal

Article Type

Topics

Tags

Filters

Specify Date Range

Atypical Presentations of Birdshot Chorioretiopathy: A Comparative Longitudinal Study

Peripapillary Choroidal Vascularity Outside the Macula in Patients With Central Serous Chorioretinopathy

Genome-wide transcriptional responses of human choroidal endothelial cells to corticosteroids as a model for central serous chorioretinopathy

Psychological Stress during COVID-19 and Central Serous Chorioretinopathy (CSCR)

Subretinal choroidal neovascularization in central serous chorioretinopathy resistant to mineralocorticoid receptor antagonists

One year outcome and predictors of treatment outcome in central serous chorioretinopathy (CSCR): multimodal imaging based analysis

Choroidal vascularity map in unilateral central serous chorioretinopathy : A comparison with fellow eyes

Choroidal Vascularity in Chronic Central Serous Chorioretinopathy

Effect of Photodynamic Therapy on Choroidal Indices in Patients with Central Serous Chorioretinopathy

Peripapillary Halos in Inflammatory Optic Neuritis of Birdshot Chorioretinopathy

The significance of double layer sign in eyes with choroidal neovascularization secondary to central serous chorioretinopathy

Macular Neovascularization Associated with Central Serous Chorioretinopathy: Multimodal Imaging-Based Predictors

Difference in characteristics of central serous chorioretinopathy with and without choroidal neovascularization on OCT angiography

Automated Detection of Inflammatory Activity in Sarcoid Uveitis and Birdshot Chorioretinopathy Patients Using Optical Coherence Tomography and Fluorescein Angiography

Dexamethasone intravitreal implant as monotherapy for birdshot chorioretinopathy

Clinical Outcome of Anti-VEGF in type 1 Choroidal Neovascularization secondary to Central Serous Chorioretinopathy

Long-term changes of fundus autofluorescence in chronic central serous chorioretinopathy

The value of OCT angiography (OCTA) to discriminate neovascular central serous chorioretinopathy（nCSC）

Endpoint management in central serous chorioretinopathy

Galectin 3 and Central Serous Chorioretinopathy: a promising new biomarker

Search Results for Chorioretinopathy

To View More...

You must be signed into an individual account to use this feature.